// App-Quantinova.ai

1054 : Distinct Differences in Complement Perturbation Between Scleroderma-related Interstitial Lung Disease with and Without Emphysema

Researchers

Presenter

  • Alice Cole

Principal Investigators

  • Claire Beesley

  • Nina Goldman

  • Odewale Oluwakorede

  • Joseph Barnett

  • David Abraham

  • Chris Denton

  • Rizgar Mageed

  • Voon Ong

Medical Centers

  • Kings College London, London, United Kingdom

  • The Royal Marsden Hospital, London, United Kingdom

  • Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom

  • UCL Med Schl Royal Free Campus, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Pulmonary/Respiratory Diseases

Disease

  • Interstitial lung disease

  • Scleroderma

  • Chronic obstructive pulmonary disease

Biomarkers

  • Complement Component 5a

  • Complement Component 3a

  • Mannan-binding lectin-associated serine protease 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved